You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cabotegravir Injectable Suspension

Showing 1 - 25 of 1,851
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Kisumu, Mbarara (Cabotegravir Injectable Suspension, Dynamic Choice Delivery Model, Standard of Care)

Recruiting
  • HIV
  • Cabotegravir Injectable Suspension
  • +2 more
  • Kisumu, Kenya
  • +1 more
Jan 18, 2023

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable

Completed
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir Injectable Suspension
  • Rilpivirine Injectable Suspension
  • Bakersfield, California
  • +31 more
May 31, 2023

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

Active, not recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir - Injectable Suspension (CAB LA)
  • Rilpivirine - Injectable Suspension (RPV LA)
  • Macon, Georgia
  • +29 more
May 31, 2023

Long-acting Injectable Cabotegravir + Rilpivirine

Not yet recruiting
  • Patient Satisfaction
  • +3 more
    • Santiago, Region Metropolitana, Chile
      CICUC
    Apr 18, 2023

    HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))

    Not yet recruiting
    • HIV Infections
    • Cabotegravir Injection [Apretude]
    • Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
    • Johannesburg, Gauteng, South Africa
      Ezintsha, a division of Wits Health Consortium
    Nov 13, 2023

    Satisfaction of HIV-infected Patients Treated With

    Not yet recruiting
    • HIV Infections
    • satisfaction survey
    • (no location specified)
    Jan 16, 2023

    Healthy Trial in Lenexa, Salt Lake City, Groningen (RPV LA, CAB LA)

    Recruiting
    • Healthy
    • RPV LA
    • CAB LA
    • Lenexa, Kansas
    • +2 more
    Jan 17, 2023

    HIV Trial in Rio De Janeiro (Cabotegravir Injection)

    Not yet recruiting
    • HIV Infections
    • Cabotegravir Injection
    • Rio De Janeiro, Brazil
      Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
    Aug 23, 2022

    HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

    Recruiting
    • HIV Infections
    • Oral Cabotegravir (CAB)
    • +4 more
    • La Jolla, California
    • +30 more
    Feb 2, 2023

    HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

    Active, not recruiting
    • HIV Infections
    • Cabotegravir Tablets
    • +4 more
    • Bakersfield, California
    • +116 more
    Jan 22, 2023

    HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

    Not yet recruiting
    • HIV-1-infection
    • Once daily CAB tablet + RPV tablet
    • Long acting CAB injectable + long acting RPV injectable
    • Atlanta, Georgia
    • +11 more
    Dec 13, 2022

    HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

    Recruiting
    • HIV-1-infection
    • Kisumu, Kenya
    • +6 more
    Feb 1, 2023

    HIV Trial in Glendale (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir extended release suspension for injection

    Completed
    • HIV Infections
    • Cabotegravir Tablets
    • +3 more
    • Glendale, California
      GSK Investigational Site
    Feb 14, 2022

    Pain, Postoperative, Opioid Use, Perioperative Complication Trial (bupivacaine liposome injectable suspension, Bupivacaine

    Not yet recruiting
    • Pain, Postoperative
    • +3 more
    • bupivacaine liposome injectable suspension
    • Bupivacaine Hydrochloride
    • (no location specified)
    Oct 4, 2023

    HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

    Not yet recruiting
    • HIV Infections
    • (no location specified)
    Jun 13, 2023

    HIV, STI Trial in Atlanta (PrEP discontinuation intervention, Offering of on-demand oral PrEP, Offering of STI PEP)

    Recruiting
    • HIV
    • STI
    • PrEP discontinuation intervention
    • +3 more
    • Atlanta, Georgia
      PRISM Research Center
    Jun 2, 2022

    HIV Trial in Worldwide (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir Injectable Suspension)

    Active, not recruiting
    Has Results
    • HIV Infections
    • Cabotegravir Tablets
    • +3 more
    • Birmingham, Alabama
    • +118 more
    Jul 14, 2021

    Inflammation, Pain, Postoperative, Trismus Trial in Granada (Dexamethasone 4 Mg/mL Injectable Solution, MethylPREDNISolone 40

    Recruiting
    • Inflammation
    • +2 more
    • Dexamethasone 4 Mg/mL Injectable Solution
    • MethylPREDNISolone 40 Mg/mL Injectable Suspension
    • Granada, Spain
      Unai Fernández Martín
    Feb 28, 2023

    Oregon PrEP at Home Study

    Not yet recruiting
    • HIV/AIDS
    • Cabotegravir Injection
    • Portland, Oregon
      Oregon Health & Science University
    Jul 15, 2023

    Sedation Complication Trial in Karachi (Propofol 1 % Injectable Suspension, Sevoflurane)

    Completed
    • Sedation Complication
    • Karachi, Sindh, Pakistan
      Syed Muhammad Abbas
    Aug 13, 2023

    PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

    Approved for marketing
    • PEComa, Malignant
    • +3 more
    • (no location specified)
    Mar 2, 2022

    Pain, Postoperative Trial in Taipei city (Marcaine® 100mg/20mL (0.5%) bupivacaine solution for Injection, ND-340 (Bupivacaine

    Recruiting
    • Pain, Postoperative
    • Marcaine® 100mg/20mL (0.5%) bupivacaine solution for Injection
    • ND-340 (Bupivacaine Microsphere), 300 mg/vial bupivacaine for extended-release injectable suspension
    • Taipei city, Taiwan
      National Taiwan University Hospital
    Oct 18, 2022

    Cesarean Section Complications Trial in Durham (Erector Spinae Plane (ESP) Block, bupivacaine liposome injectable suspension,

    Not yet recruiting
    • Cesarean Section Complications
    • Erector Spinae Plane (ESP) Block
    • +2 more
    • Durham, North Carolina
      Duke University Hospital
    Dec 16, 2022

    Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Phoenix, Arizona
      Retinal Research Institute, LLC
    Jun 4, 2023

    Alcohol Use Disorder, Alcoholism Trial in Philadelphia (XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo

    Recruiting
    • Alcohol Use Disorder
    • Alcoholism
    • XR-NTX 380 mg, intramuscular injection
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Center for Studies of Addiction
    Jun 6, 2022